FDA Adverse Event Malfunction Summary report: N

CONTROL SET FOR THE BD PROBETEC (CT/GC) QX AMPLIFIED DNA ASSAYS

MDR report key: 11308646 · Received February 10, 2021

Report

Report Number
1119779-2021-00283
Event Type
Malfunction
Date Received
February 10, 2021
Date of Event
December 14, 2020
Report Date
January 22, 2021
Manufacturer
BECTON, DICKINSON & CO. (SPARKS)
Product Code
LSL
UDI-DI
00382904411251
PMA / PMN Number
K081825
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INVESTIGATION SUMMARY: BD MOLECULAR QUALITY INITIATED INVESTIGATION ON THE CUSTOMER REPORT REGARDING SEVERAL INVALID CT/GC POSITIVE CONTROL RESULTS. QUALITY INVESTIGATION REQUIRED REVIEW OF THE BATCH HISTORY RECORDS AND FUNCTIONAL ANALYSIS OF RETENTION MATERIALS FROM THE CUSTOMERS REPORTED REAGENT BATCH AS WELL AS COMPLAINT TRENDING REVIEW. THE BATCH HISTORY RECORDS WERE REVIEWED AND NO DISCREPANCIES WERE NOTED. FUNCTIONAL ANALYSIS OF RETENTION MATERIALS PASSED WITH 100% POSITIVITY FOR CT AND GC. QUALITY WAS UNABLE TO DUPLICATE THE CUSTOMERS REPORTED FAILURE MODE. THERE ARE NO CURRENT COMPLAINT TRENDS AGAINST INVALID CT/GC POSITIVE CONTROL RESULTS ON THE VIPER XTR SYSTEM. BD MOLECULAR QUALITY WILL CONTINUE TO CLOSELY MONITOR FOR TRENDS ASSOCIATED WITH INVALID CT/GC POSITIVE CONTROL RESULTS.

Description of Event or Problem · 1

IT WAS REPORTED THAT WHILE USING CONTROL SET FOR THE BD PROBETEC¿ (CT/GC) QX AMPLIFIED DNA ASSAYS 4 FALSE NEGATIVE RESULTS WERE OBTAINED BY THE LABORATORY PERSONNEL. THERE WAS NO INDICATION THAT RESULTS WERE REPORTED OUT AND THERE WAS NO REPORT OF PATIENT IMPACT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
203749 CONTROL SET FOR THE BD PROBETEC (CT/GC) QX AMPLIFIED DNA ASSAYS DNA REAGENTS, NEISSERIA LSL BECTON, DICKINSON & CO. (SPARKS) 441125 0247078 00382904411251

Patients

Seq Age Sex Outcome Treatment
1